New COVID vaccine approved by US FDA: Here's all about it
Just new variants of the coronavirus causing COVID are emerging, the US Food and Drug Administration (US FDA) has approved a new vaccine against COVID. The vaccine has been manufactured by Moderna.
"Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE (mRNA-1283), a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC)," the pharma maker has said in a press release.
COVID killed 47,000 Americans in 2024.
"The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19," said Stéphane Bancel, Chief Executive Officer of Moderna. "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Buy Brass Idols - Handmade Brass Statues for Home & Gifting
Luxeartisanship
Buy Now
Undo
"
What is mNEXSPIKE?
mNEXSPIKE is a COVID-19 vaccine meant for folks who've already had a previous COVID shot. It's mainly for people aged 65 and older, or anyone between 12 and 64 who's at high risk of getting really sick from the virus. Just a heads-up though—like all vaccines, it's not a guaranteed shield for everyone, but it does offer an extra layer of protection for those who need it most.
"You should not get mNEXSPIKE if you hada severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (COVID-19 Vaccine, mRNA), or any Moderna COVID-19 vaccine or to any ingredient in these vaccines," Moderna has warned. The side effects are trouble breathing, swelling of face and throat, fast heart beat, rashes, dizziness and weakness.
Moderna expects to have mNEXSPIKE available for eligible populations in the U.S. for the 2025-2026 respiratory virus season, alongside Spikevax and mRESVIA, the Company's approved respiratory syncytial virus (RSV) vaccine.
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
India's active Covid case tally reaches 3,758, Kerala, Karnataka report 2 deaths
Covid-19 active cases in India have risen to over 3,700—marking the first significant surge in months—with more than 360 new infections reported in the past 24 hours, as per Ministry of Health and Family Welfare (MoHFW) data on Sunday, June 1. As of Sunday, Kerala, Maharashtra, and Delhi have logged the most Covid-19 active cases at 1400, 485 and 436 respectively. Meanwhile, the country also logged two Covid-19-related death in the 24-hour period, MoHFW data on Sunday showed. Covid-19 active cases in India: As mentioned above in this report, India currently has a total of 3,758 active cases of Covid-19, with 363 fresh infections reported between Saturday and Sunday - May 31 and June 1. Most cases in these states: Kerala tops the Covid tally chart with 1400 active cases, followed by Maharashtra (485 cases) and Delhi (436 cases). Kerala, Maharashtra and Delhi logged 64, 18 and 61 fresh cases, respectively, in the last 24 hours, as per MoHFW data. Covid deaths in India: India also reported two Covid-19-related death - one each in Kerala and Karnataka - in the 24-hour period, MoHFW figures on Sunday showed. In Karnataka, a 63 year old man with Pulmonary TB, Squamous Cell Carcinoma of buccal mucosa and incidental Covid positive status died, while in Kerala, a 24-year-old woman with Covid-19 and Sepsis Hypertension, DCLD (Decompensated Chronic Liver Disease), succumbed to the disease, as per the health ministry. Karnataka issues advisory: In the wake of recent increase in Covid-19 cases in the state, the Karnataka government on Saturday issued a public advisory, asking people to practice responsible behaviour by wearing masks in crowded places, maintaining physical distancing, and practicing good hygiene. Covid death in Delhi: A 60-year-old woman who tested positive for Covid-19 died in Delhi, officials said on Saturday. This is the first fatality in Delhi amid the current surge in cases. "The woman was suffering from acute intestinal obstruction post-laparotomy. The Covid-19 finding was incidental," PTI news agency quoted an official.
Time of India
an hour ago
- Time of India
Woman sheds 4 stone(25 kilos) in 4 months on Mounjaro, then suffers liver failure—how the drug works and its risks
Aimee Chapman, 34, from Southampton, lost four stone in just four months using Mounjaro—but her rapid transformation came at a devastating cost. The former waitress was admitted to intensive care last summer with liver failure and a perforated oesophagus, complications doctors directly linked to the weight-loss injection. Tired of too many ads? go ad free now Chapman had purchased Mounjaro from a major online pharmacy in March 2024, hoping that losing weight would help her be 'taken more seriously' by doctors after being diagnosed with fibromyalgia, a chronic pain disorder. At first, the results were everything she hoped for. But just a few months in, her health began to unravel. "I couldn't really do much. I was only eating a couple of times a week," she said. "I stopped being able to walk. I would take a couple of steps and have to stop. Then I couldn't stop being sick. I was throwing up all the time and started throwing up blood. I was sick between 50 and 60 times." Chapman collapsed multiple times. "My husband came home and found me passed out on the hallway one night," she said. Initially, she believed it was a virus. 'I was in a bit of denial about it being linked to the jab because I was fine up until now.' It wasn't until she experienced severe chest pains that she went to Winchester Hospital A&E. There, doctors discovered a hole in her oesophagus—allowing air to leak around her heart and lungs. As her blood pressure and potassium levels dropped, she was transferred to intensive care at Southampton General Hospital, where doctors found her liver was 'failing.' A transplant was considered. "They had said it was down to the weight-loss jab but they didn't know why or how to fix it," she said. "I was terrified. It all happened so quickly… I was told the hole in the oesophagus can kill people and I may have needed a new liver. Tired of too many ads? go ad free now They said I could've died." Though her condition was stabilized within two weeks, her ordeal continued. By September, she began losing large clumps of hair—eventually diagnosed as a vitamin B12 deficiency. 'It kept happening and the handfuls kept getting bigger. I would be so sad,' she said. 'My hair was such a massive part of my identity and to cut it off just felt really traumatic.' While she doesn't want to 'tell people what they can and can't take,' Chapman says, 'I regret ever taking them. I'd say to other people thinking about trying them, don't do it online, go through your doctor who can give you blood tests and check how you're doing.' What exactly is Mounjara? According to Mounjaro (tirzepatide) is a once-weekly injection primarily prescribed to manage type 2 diabetes by lowering blood sugar levels. In addition to its intended purpose, the medication is also known to promote weight loss. It is meant to be used alongside a healthy diet and regular exercise. The U.S. Food and Drug Administration (FDA) approved Mounjaro on May 13, 2022, and got a at the end of 2023 for weight loss in adults. Currently, there is no generic version available. Tirzepatide is sold under two brand names—Mounjaro and Zepbound—both manufactured by Eli Lilly and Company. While they contain the same active ingredient, they are approved for different medical uses. How does Mounjaro work? According to the National Library of Medicine, mounjaro (tirzepatide) works through a unique dual-action approach by targeting two key gut hormone receptors. Here's how it helps manage blood sugar and promote weight loss: Activates Two Hormone Receptors Slows Down Stomach Emptying Controls Appetite Increases Satiety Influences Brain Reward Pathways What are the known side effects? Like many medications in its class, Mounjaro is associated with a range of side effects, most of which involve the gastrointestinal (GI) system. According to Eli Lilly and Co. and the U.S. Food and Drug Administration ( ), the most commonly reported side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain or discomfort Decreased appetite Indigestion or heartburn
&w=3840&q=100)
First Post
2 hours ago
- First Post
Four new Covid cases detected in Gurugram, total rises to 23 in latest surge
Four more people were diagnosed with coronavirus infection in Gurugram on Sunday, a health department official said. read more Four new coronavirus cases were reported in Gurugram on Sunday, bringing the total number of infections during the latest resurgence to 23, according to the district health department. Officials said 12 of the cases are currently active, with all patients experiencing only mild symptoms and recovering in home isolation. A total of 97 samples were collected on Sunday for testing. Gurugram is witnessing a surge in the COVID cases after two and a half years. STORY CONTINUES BELOW THIS AD Civil Surgeon Dr Alka Singh appealed to the general public not to ignore its flu-like symptoms and immediately contact the nearest health centre and get a corona test.
